Liz Nichols is a construction worker and artist in Portland, Ore. She posts poems and art on Instagram @graydaygoods.

Protagonist (PTGX) is a high-conviction buy: late-stage icotrokinra & rusfertide near 2026 milestones, strong cash runway. Read more here.

Scientists are developing a microneedle patch that they hope could someday simplify IVF hormone delivery. They've tested it ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the ...

Raises 2026 Financial Guidance Ranges: – Increases Total Revenue to $1,710 – $1,810 million, YoY Growth of 23% to 30%2 – ...

Khaberni - The field of heart diseases is undergoing rapid scientific transformations that are no longer measured by a ...

An updated edition of the December 16, 2025, article. An aging U.S. population is becoming a first-order driver of consumption reallocation. Going by the data from the United States Census Bureau, by ...

Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way ...

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

AstraZeneca has hit what appears to be a minor speed bump in gaining clearance in the U.S. for its subcutaneous (SC) version of lupus treatment Saphnelo. | AstraZeneca will have to negotiate what ...

Mounjaro (tirzepatide) is prescribed to manage blood sugar levels in people with type 2 diabetes. It’s available as a single-dose prefilled pen. You will administer your Mounjaro injections into your ...

AstraZeneca has already provided the requested information to the FDA and a decision on the updated BLA is expected in the first half of 2026.